ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2022.0.179 2022.0.179 true2022-04-01false1712falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 11030484 2022-04-01 2023-03-31 11030484 2023-03-31 11030484 2021-04-01 2022-03-31 11030484 2022-03-31 11030484 c:Director1 2022-04-01 2023-03-31 11030484 c:Director2 2022-04-01 2023-03-31 11030484 d:Buildings d:LongLeaseholdAssets 2022-04-01 2023-03-31 11030484 d:Buildings d:LongLeaseholdAssets 2023-03-31 11030484 d:Buildings d:LongLeaseholdAssets 2022-03-31 11030484 d:PlantMachinery 2022-04-01 2023-03-31 11030484 d:PlantMachinery 2023-03-31 11030484 d:PlantMachinery 2022-03-31 11030484 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 11030484 d:ComputerEquipment 2022-04-01 2023-03-31 11030484 d:ComputerEquipment 2023-03-31 11030484 d:ComputerEquipment 2022-03-31 11030484 d:ComputerEquipment d:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 11030484 d:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 11030484 d:Goodwill 2022-04-01 2023-03-31 11030484 d:Goodwill 2023-03-31 11030484 d:Goodwill 2022-03-31 11030484 d:CurrentFinancialInstruments 2023-03-31 11030484 d:CurrentFinancialInstruments 2022-03-31 11030484 d:Non-currentFinancialInstruments 2023-03-31 11030484 d:Non-currentFinancialInstruments 2022-03-31 11030484 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 11030484 d:CurrentFinancialInstruments d:WithinOneYear 2022-03-31 11030484 d:Non-currentFinancialInstruments d:AfterOneYear 2023-03-31 11030484 d:Non-currentFinancialInstruments d:AfterOneYear 2022-03-31 11030484 d:ShareCapital 2023-03-31 11030484 d:ShareCapital 2022-03-31 11030484 d:RetainedEarningsAccumulatedLosses 2023-03-31 11030484 d:RetainedEarningsAccumulatedLosses 2022-03-31 11030484 c:FRS102 2022-04-01 2023-03-31 11030484 c:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 11030484 c:FullAccounts 2022-04-01 2023-03-31 11030484 c:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 11030484 d:Goodwill d:ExternallyAcquiredIntangibleAssets 2022-04-01 2023-03-31 11030484 2 2022-04-01 2023-03-31 11030484 d:Goodwill d:OwnedIntangibleAssets 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure
Registered number: 11030484













Lynwood Healthcare Ltd

Financial statements
Information for filing with the registrar

31 March 2023




 
Lynwood Healthcare Ltd


Balance Sheet
At 31 March 2023

2023
2022
Note
£
£

Fixed assets
  

Intangible assets
 5 
1,592,175
160,050

Tangible assets
 6 
96,465
31,995

  
1,688,640
192,045

Current assets
  

Stocks
  
10,000
6,200

Debtors: amounts falling due within one year
 7 
106,738
211,103

Bank and cash balances
  
230,020
56,568

  
346,758
273,871

Creditors: amounts falling due within one year
 8 
(526,012)
(74,780)

Net current (liabilities)/assets
  
 
 
(179,254)
 
 
199,091

Total assets less current liabilities
  
1,509,386
391,136

Creditors: amounts falling due after more than one year
 9 
(1,089,201)
(19,454)

Provisions for liabilities
  

Deferred tax
  
(22,873)
(6,852)

  
 
 
(22,873)
 
 
(6,852)

Net assets
  
397,312
364,830


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
397,212
364,730

Shareholders' funds
  
397,312
364,830


1

 
Lynwood Healthcare Ltd

    
Balance Sheet (continued)
At 31 March 2023

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 11 December 2023.




Kashif Ahmad
Bilal Mohammed Ahmad
Director
Director

Registered number: 11030484
The notes on pages 3 to 7 form part of these financial statements. 

2

 
Lynwood Healthcare Ltd
 
 

Notes to the financial statements
Year ended 31 March 2023

1.


General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 10 Samson Close, Killingworth, Newcastle upon Tyne, NE12 6DX, United Kingdom.


2.


Standard of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3.Accounting policies

 
3.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
3.2

Revenue

The turnover shown in the profit and loss account represents private fees and capitation schemes income receivable during the period.

 
3.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
3.4

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3

 
Lynwood Healthcare Ltd
 

 
Notes to the financial statements
Year ended 31 March 2023

3.Accounting policies (continued)

 
3.5

Intangible assets

Goodwill

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the statement of comprehensive income over its useful economic life.

Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
3.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Long-term leasehold property
-
2%
straight line
Plant and machinery
-
25%
reducing balance
Computer equipment
-
20%
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
3.7

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

4

 
Lynwood Healthcare Ltd
 

 
Notes to the financial statements
Year ended 31 March 2023

3.Accounting policies (continued)

 
3.8

Provisions for liabilities

Provisions are made where an event has taken place that gives the company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the company becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the balance sheet.

 
3.9

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.


4.


Employees

The average monthly number of employees, including directors, during the year was 17 (2022 - 12).


5.


Intangible assets




Goodwill

£



Cost


At 1 April 2022
194,000


Additions
1,498,000



At 31 March 2023

1,692,000



Amortisation


At 1 April 2022
33,950


Charge for the year on owned assets
65,875



At 31 March 2023

99,825



Net book value



At 31 March 2023
1,592,175



At 31 March 2022
160,050


5

 
Lynwood Healthcare Ltd
 
 

Notes to the financial statements
Year ended 31 March 2023
 
           5.Intangible assets (continued)



6.


Tangible fixed assets





Long-term leasehold property
Plant and machinery
Computer equipment
Total

£
£
£
£



Cost or valuation


At 1 April 2022
3,914
52,183
-
56,097


Additions
-
79,320
702
80,022



At 31 March 2023

3,914
131,503
702
136,119



Depreciation


At 1 April 2022
78
24,023
-
24,101


Charge for the year on owned assets
78
15,405
70
15,553



At 31 March 2023

156
39,428
70
39,654



Net book value



At 31 March 2023
3,758
92,075
632
96,465



At 31 March 2022
3,835
28,160
-
31,995


7.


Debtors

2023
2022
£
£


Trade debtors
64,822
2,883

Amounts owed by joint ventures and associated undertakings
1,687
1,687

Other debtors
40,229
206,533

106,738
211,103


6

 
Lynwood Healthcare Ltd
 
 

Notes to the financial statements
Year ended 31 March 2023

8.


Creditors: Amounts falling due within one year

2023
2022
£
£

Bank loans
16,218
6,035

Trade creditors
98,183
18,042

Corporation tax
12,070
26,819

Other taxation and social security
7,043
9,487

Other creditors
359,456
10,557

Accruals and deferred income
33,042
3,840

526,012
74,780



9.


Creditors: amounts falling due after more than one year

2023
2022
£
£

Bank loans
1,089,201
19,454

1,089,201
19,454



10.


Related party transactions

The directors are also directors and shareholders in the company Lynwood Property Ltd.
The company held an intercompany loan account with Lynwood Property Ltd. At 31 March 2023, the amount outstanding was £1,687 (2022: £1,687) due from Lynwood Property Ltd.

 
7